Table 1 Demographic and clinical characteristics associated with the odds of being seen at the smoking cessation clinic at KHCC in a sample of 3403 Jordanian cancer patients who smoke (column totals presented). A total of 717 cancer patients were seen at the clinic while 2686 were not
Variable: | Proportion seen at the clinic (n) | Unadjusted odds ratio of being seen (95% CI) | Adjusted odds ratio (of being seen) |
|---|---|---|---|
Gender | |||
 Males (N = 2454) | 23.5% (n = 576) | Reference group | Reference group |
 Females (N = 949) | 14.9% (n = 141) | 0.59 (0.46–0.70) | 0.49 (0.38–0.63) |
Age at diagnosis | |||
 18–30 (N = 278) | 21.9% (n = 61) | Reference group | Reference group |
 31–40 (N = 491) | 17.5% (n = 86) | 0.76 (0.52–1.1) | 0.89 (0.57–1.4) |
 41–50 (N = 776) | 24.4% (n = 189) | 1.1 (0.83–1.6) | 1.3 (0.82–1.9) |
 51–60 (N = 860) | 24.2% (n = 208) | 1.1 (0.82–1.6) | 1.1 (0.73–1.7) |
 61–70 (N = 675) | 19.1% (n = 129) | 0.84 (0.60–1.2) | 0.78 (0.49–1.2) |
  > 70 (N = 323) | 13.6% (n = 44) | 0.56 (0.37–0.86) | 0.49 (0.29–0.85) |
Diagnosis year | |||
 2009 (N = 256) | 14.8% (n = 38) | Reference group | Reference group |
 2010 (N = 382) | 13.1% (n = 50) | 0.86 (0.55–1.4) | 0.85 (0.53–1.4) |
 2011 (N = 378) | 14.3% (n = 54) | 0.96 (0.61–1.5) | 0.94 (0.60–1.5) |
 2012 (N = 329) | 13.4% (n = 44) | 0.89 (0.55–1.4) | 0.86 (0.53–1.4) |
 2013 (N = 416) | 15.9% (n = 66) | 1.1 (0.70–1.7) | 1.0 (0.66–1.6) |
 2014 (N = 492) | 20.7% (n = 102) | 1.5 (0.99–2.3) | 1.4 (0.91–2.1) |
 2015 (N = 572) | 28.5% (n = 163) | 2.3 (1.5–3.4) | 2.4 (1.6–3.6) |
 2016 (N = 578) | 34.6% (n = 200) | 3.0 (2.1–4.5) | 3.3 (2.2–4.9) |
Marital status | |||
 Married (N = 2825) | 21.3% (n = 601) | Reference group | Reference group |
 Single (N = 378) | 18.5% (n = 70) | 0.84 (0.64–1.1) | 0.88 (0.62–1.3) |
 Separated/divorced/widowed (N = 200) | 23.0% (n = 46) | 1.1 (0.79–1.6) | 1.4 (0.93–2.0) |
Geographic area | |||
 Central (N = 2860) | 21.4% (n = 613) | Reference group | Reference group |
 North (N = 350) | 19.1% (n = 67) | 0.87 (0.66–1.1) | 0.74 (0.55–0.99) |
 South (N = 192) | 19.3% (n = 37) | 0.88 (0.60–1.3) | 0.80 (0.55–1.2) |
Tumor type and relation to tobacco | |||
 Solid, tobacco-relateda (N = 851) | 25.5% (n = 217) | Reference group | Reference group |
 Solid, tobacco-related (other)b (N = 827) | 20.1% (n = 166) | 0.73 (0.58–0.92) | 0.57 (0.43–0.75) |
 Solid, not tobacco-related (N = 1186) | 16.8% (n = 199) | 0.59 (0.48–0.73) | 0.51 (0.38–0.69) |
 Hematological, tobacco-related (N = 60) | 13.3% (n = 8) | 0.45 (0.21–0.96) | 0.52 (0.23–1.2) |
 Hematological, not tobacco-related (N = 478) | 26.6% (n = 127) | 1.1 (0.82–1.4) | 1.1 (0.8–1.5) |
Stage | |||
 In-situ (N = 107) | 29.9% (n = 32) | 1.6 (1.03–2.5) | 1.7 (1.03–2.8) |
 Local (N = 797) | 20.8% (n = 166) | Reference group | Reference group |
 Regional (N = 1229) | 22.8% (n = 280) | 1.1 (0.90–1.4) | 0.95 (0.74–1.2) |
 Distant or unstaged (N = 1270) | 18.8% (n = 239) | 0.89 (0.71–1.1) | 0.54 (0.40–0.71) |
Received chemotherapy | |||
 No (N = 1027) | 19.6% (n = 201) | Reference group | Reference group |
 Yes (N = 2376) | 21.7% (n = 516) | 1.14 (0.95–1.5) | 1.4 (1.1–1.8) |
Received surgery | |||
 No (N = 2153) | 21.0% (n = 451) | Reference group | Reference group |
 Yes (N = 1250) | 21.3% (n = 266) | 1.0 (0.86–1.2) | 1.0 (0.80–1.3) |
Received radiation | |||
 No (N = 1867) | 21.2% (n = 395) | Reference group | Reference group |
 Yes (N = 1536) | 21.0% (n = 322) | 0.99 (0.84–1.2) | 0.96 (0.78–1.2) |
Received hormonal therapy | |||
 No (N = 2944) | 21.8% (n = 643) | Reference group | Reference group |
 Yes (N = 459) | 16.1% (n = 74) | 0.69 (0.53–0.90) | 1.3 (0.94–1.9) |
Received immunotherapy | |||
 No (N = 3331) | 20.9% (n = 696) | Reference group | Reference group |
 Yes (N = 72) | 29.2% (n = 21) | 1.6 (0.93–2.6) | 1.6 (0.92–3.0) |
Received BMT | |||
 No (N = 3283) | 20.9% (n = 687) | Reference group | Reference group |
 Yes (N = 120) | 25.0% (n = 30) | 1.3 (0.83–1.9) | 1.6 (0.99–2.5) |
Have diabetes | |||
 No (N = 2826) | 20.7% (n = 586) | Reference group | Reference group |
 Yes (N = 577) | 22.7% (n = 131) | 1.1 (0.91–1.4) | 0.99 (0.77–1.3) |
Have respiratory disease | |||
 No (N = 3122) | 20.9% (n = 653) | Reference group | Reference group |
 Yes (N = 281) | 22.8% (n = 64) | 1.1 (0.83–1.5) | 0.98 (0.70–1.4) |
Have cardio- or cerebrovascular disease | |||
 No (N = 2464) | 20.5% (n = 506) | Reference group | Reference group |
 Yes (N = 939) | 22.5% (n = 211) | 1.1 (0.94–1.3) | 1.1 (0.90–1.4) |